venBio Partners L.P.

Q4 2018 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    3

  • Value ($000)

    $38,077

  • Date Filed
    02/14/2019
  • Form type
    13F-HR
  • CIK
    0001737053
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2018 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

Apellis Pharmaceuticals, Inc

COM
037530106
$23.61M
62 %

1,790,102

VRNA
VRNA

Verona Pharma PLC

SPONSORED ADS
925050106
$8.44M
22 %

875,000

MNLOUSD
MNLOUSD

Menlo Therapeutics Inc.

COM
586858102
$6.02M
16 %

1,461,552

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 3 of 3